Lack of Association Between Hemoglobin A1c and Continuous Glucose Monitor Metrics Among Individuals with Prediabetes
Jorge A Rodriguez1,2, Nadine E Palermo2,3, Wenyu Song1,2
1Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Insights
Continuous glucose monitor (CGM) metrics do not reliably reflect hemoglobin A1c (HbA1c) in prediabetes or normoglycemia. Associations are strongest in type 2 diabetes, but weaken significantly in lower glycemic states.
Area of Science:
- Endocrinology
- Metabolic Health
- Diabetes Technology
Background:
- Continuous glucose monitors (CGMs) offer detailed glycemic insights.
- The correlation between CGM metrics and hemoglobin A1c (HbA1c) in prediabetes and normoglycemia is not well-established.
Purpose of the Study:
- To investigate the association between various CGM metrics and HbA1c across different glycemic statuses: type 2 diabetes, prediabetes, and normoglycemia.
- To determine if standard CGM metrics can accurately reflect HbA1c levels in individuals without diabetes.
Main Methods:
- Analysis of data from 972 individuals stratified by glycemic status (421 type 2 diabetes, 319 prediabetes, 232 normoglycemia).
- Examined associations between eight CGM metrics and HbA1c using regression analysis.
- Assessed interaction terms to evaluate differences across glycemic groups.
Main Results:
- Strongest associations between CGM metrics and HbA1c were observed in the type 2 diabetes group, particularly mean glucose (standardized β = 0.79).
- In prediabetes, associations were attenuated, with mean glucose showing a moderate relationship (standardized β = 0.22).
- For normoglycemic individuals, CGM metrics showed minimal association with HbA1c, including a weak link with mean glucose (standardized β = 0.10) and no significant relationship for time in range.
Conclusions:
- Standard CGM metrics should be interpreted cautiously and are not interchangeable with HbA1c measurements in individuals with prediabetes or normoglycemia.
- Glycemic status significantly modifies the relationship between CGM-derived metrics and HbA1c.
- Further research may be needed to establish appropriate interpretation guidelines for CGM data in non-diabetic glycemic states.
Abstract:
Continuous glucose monitors (CGMs) are becoming increasingly available, yet the relationship between CGM metrics and hemoglobin A1c (HbA1c) among individuals with prediabetes and normoglycemia remains unclear. We examined associations between HbA1c and eight CGM metrics across glycemic status. Our cohort included 972 individuals: 421 (43.3%) with type 2 diabetes, 319 (32.8%) with prediabetes, and 232 (23.9%) with normoglycemia. Associations were strongest in type 2 diabetes, with mean glucose showing the strongest relationships (standardized β = 0.79, P < 0.001). In prediabetes, associations were substantially attenuated, with mean glucose showing moderate association (standardized β = 0.22, P < 0.001). Among individuals with normoglycemia, CGM metrics showed minimal associations with HbA1c, with mean glucose demonstrating a weak association (standardized β = 0.10, P = 0.022) and time in range showing no significant relationship. All interaction terms were statistically significant (P < 0.001). These findings suggest that standard CGM metrics should not be interpreted to reflect HbA1c for individuals with prediabetes and normoglycemia.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Hypoglycemia and Glucagon
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...


